AVONEX 30 micrograms/0.5 ml, solution for injection 4 syringes of 0.5 ml
Active ingredients: Interferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection4 syringes of 0.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AVONEX 30 microgrammes/0,5 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 4 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s)
- Marketing authorisation holder
- BIOGEN NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Oct 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62493653CIP73432326CIP133400934323263Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INTERFÉRON BÊTA-1Asolution | 30 microgrammes · 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.